The US Preventive Services Task Force has seats filled for the first time in over a year. Health Secretary Robert F. Kennedy Jr., who had deliberately sidelined the 16-person federal panel by canceling its meetings and declining to replace members as terms expired, announced eight new appointments. That the body can now convene is one thing. What it will do with that capacity is another.
The USPSTF occupies an unusual position in American healthcare. Its recommendations carry a legal mandate: health insurers must cover, at no cost to patients, any preventive service the panel grades A or B on its scoring scale. Depression screening, mammograms, colonoscopies, statin use: the panel's letter grades are direct coverage triggers. When the panel cannot meet, that review process stops. The year-plus vacancy froze it entirely, meaning no new recommendations and no updated grades for insurers to act on.
What Kennedy has already done
Kennedy's record with federal advisory panels gives the appointments their full weight. In May, he fired two of the USPSTF's leaders, drawing sharp outcry and intensifying fears about his intentions for the body. Those fears were already grounded in precedent. He had stacked an influenza vaccine advisory committee at the Centers for Disease Control and Prevention with ideological allies, overriding the kind of independent, evidence-based process the USPSTF is designed to run.
The counterargument is the most direct version of the case for these appointments: a panel that cannot meet cannot do anything at all. Eight new members gives the USPSTF the numbers it needs to function, and the specific credentials of Kennedy's picks have not been reported publicly. It remains possible that some of the appointments lean toward the body's scientific tradition rather than away from it.
On balance, the read-through from the CDC committee is the harder fact to set aside. Kennedy has shown a clear preference for advisory bodies that validate rather than scrutinize. The risk is that the CDC committee is already the answer to what these appointments will look like. The USPSTF's graded recommendations carry direct legal coverage consequences that panel did not. The line to watch is whether these new members' professional records, once examined, differ from what Kennedy installed at the CDC. If they do not, the effects are not procedural. They are medical and financial.